Clinical Trial Update: TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060) [Phase 3]

View source ↗

Summary

Completed Phase 3 trial TWICE evaluated ezetimibe together with any statin for lowering cholesterol in hypercholesterolemia and hyperlipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Statin (any) (statin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolaemia, Hyperlipidaemia | Phase 3 | Status: COMPLETED